CACaption Management, LLC
Institutional investor · Portfolio as of Q2 2026
Top Holdings1,595 positions
META PLATFORMS INC | 2M | $1.1B | 5.1% | — | — | — | Decreased — |
WESTERN DIGITAL CORP | 996,000 | $636.2M | 3.0% | — | — | — | Increased — |
NVIDIA CORPORATION | 1.8M | $367.9M | 1.7% | $186.30 | +23.72% | 4 qtrssince 2025-Q3 | Increased 59 |
AMAZON COM INC | 1.3M | $312.9M | 1.5% | — | — | — | Increased — |
WARNER BROS DISCOVERY INC | 11.5M | $307.2M | 1.4% | — | — | — | Decreased — |
NVIDIA CORPORATION | 1.5M | $296.1M | 1.4% | — | — | — | Decreased — |
MICROSOFT CORP | 752,000 | $280.5M | 1.3% | — | — | — | Increased — |
TAIWAN SEMICONDUCTOR MANUFAC | 583,000 | $278.4M | 1.3% | — | — | — | Increased — |
TAIWAN SEMICONDUCTOR MANUFAC | 565,700 | $270.2M | 1.3% | $476.29 | -3.84% | 1 qtr | New 70 |
TAKE-TWO INTERACTIVE SOFTWAR | 1M | $260.7M | 1.2% | — | — | — | Increased — |
CARVANA CO | 3.8M | $249.9M | 1.2% | — | — | — | Increased — |
BLUE OWL CAPITAL INC | 23.9M | $209.3M | 1.0% | — | — | — | Increased — |
UNITED THERAPEUTICS CORP DEL | 378,200 | $204.9M | 1.0% | — | — | — | Decreased — |
UNITED THERAPEUTICS CORP DEL | 366,600 | $198.6M | 0.9% | — | — | — | Decreased — |
CARVANA CO | 3M | $195.8M | 0.9% | — | — | — | Increased — |
MICROSOFT CORP | 515,000 | $192.1M | 0.9% | $377.65 | +38.39% | 3 qtrssince 2025-Q4 | Increased 69 |
MICROSOFT CORP | 500,000 | $186.5M | 0.9% | — | — | — | Increased — |
VANECK ETF TRUST | 265,000 | $173.8M | 0.8% | — | — | — | New — |
GILEAD SCIENCES INC | 1.3M | $170.3M | 0.8% | — | — | — | Increased — |
TESLA INC | 400,000 | $168.2M | 0.8% | — | — | — | Increased — |
Caption Management, LLC manages $21.5B across 1595 positions as of Q2 2026. Top holdings: META calls (5.1%), WDC puts (3.0%), NVDA (1.7%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 237 new positions, 232 exits, 116 increased. Top move: TSM (NEW, conviction 70). Portfolio: $21.5B across 1595 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR